Royal Society of Chemistry, New Journal of Chemistry, 42(44), p. 18347-18361, 2020
DOI: 10.1039/d0nj03844j
Full text: Unavailable
Zn(ii) and Cu(ii) Schiff base complexes having DNA and HSA binding efficacy have been exploited as cancer therapeutic agents.